Clik here to view.
Biosceptre Closes AUD5m Financing from Existing Investors
CAMBRIDGE, England Biosceptre International Limited, the oncology company developing antibody products that target the nf-P2X7 receptor, today announced that it has raised AU$5m through a syndicate...
View ArticleClik here to view.
Covidien Launches EverFlex™ Self-expanding Peripheral Stent with Entrust™...
DUBLIN, Ireland Covidien plc today announced the launch of its EverFlex™ Self-expanding Peripheral Stent with Entrust™ Delivery System in Australia and New Zealand. The latest version of the...
View ArticleClik here to view.
Clik here to view.
Neptune™ Waterproof Cochlear Implant Sound Processor from Advanced Bionics...
VALENCIA, Calif. Advanced Bionics (AB), the global leader in cochlear implant technology and a company of the Sonova Group, announced today that it received approval by the China State Food and Drug...
View ArticleClik here to view.
领先仿生公司的Neptune™防水型人工耳蜗植入体声音处理器在华获得批准
加州瓦伦西亚 (美国商业资讯)–索诺瓦集团(Sonova Group)旗下全球领先的人工耳蜗植入体技术企业领先仿生有限公司(Advanced Bionics, AB)今天宣布，该公司的Neptune™声音处理器已经获得中国国家食品药品监督管理总局的批准。Neptune™是全球首款也是唯一一款可在游泳时使用的防水型人工耳蜗植入体声音处理器。 Award-winning, waterproof...
View ArticleClik here to view.
Letter to NovaBay Shareholders
EMERYVILLE, Calif. NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on non-antibiotic anti-infectives, announced today the distribution of a letter from Ron...
View ArticleClik here to view.
Otsuka and Lundbeck Submit New Drug Application in the US for Brexpiprazole...
TOKYO & COPENHAGEN, Denmark Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S, today announced the submission of a New Drug Application (NDA) to the United States Food and Drug Administration...
View ArticleClik here to view.
FDA Grants Special Protocol Assessment (SPA) Agreement for Starpharma Phase 3...
MELBOURNE, Australia Starpharma Holdings Ltd (ASX:SPL) (OTCQX:SPHRY) today announced that the US Food and Drug Administration (FDA) has granted Special Protocol Assessment (SPA) agreement on the...
View ArticleClik here to view.
NeuroVision Imaging Eye Test Shows Potential for Early Detection of Changes...
SACRAMENTO, Calif. NeuroVision Imaging, LLC announced today that preliminary results of a major clinical trial show the company’s investigational noninvasive imaging system appeared to detect...
View ArticleClik here to view.
BioTime Announces Issuance of 14 Patents in the Fields of Regenerative...
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT:BTX) announced today the issuance of 14 new patents to BioTime and its subsidiary companies. The patents issued in Australia, Canada, China, Japan, and the...
View ArticleClik here to view.
dorsaVi to Commence Sale of ViMove in the US Following FDA Clearance
MELBOURNE, Australia Wearable medical device company dorsaVi Limited (ASX:DVL) has today announced it will commence launch of ViMove in the United States following 510K clearance by the US Food and...
View ArticleClik here to view.
Toshiba Launches Tag IC with Wired Interface Compliant with NFC Forum Type 3 Tag
TOKYO Toshiba Corporation (TOKYO:6502) today announced the launch of “T6NE7”, a tag IC compliant with NFC[1] Forum Type 3 Tag[2], with embedded wired interface. Sample shipments start today, with...
View ArticleClik here to view.
東芝：NFC Forum Type 3 Tag準拠 有線インターフェース付ICの製品化について
東京 （ビジネスワイヤ） — 東芝は、NFC注1 Forum Type 3 Tagに準拠注2し、ホストマイコンとの有線インターフェースを持つTag LSI「T6NE7」を製品化しました。本日からサンプル出荷を開始し、8月から量産を開始する予定です。 近年、Bluetooth®注3、 ワイヤレスLANなど、無線通信機能を搭載したワイヤレス機器が増えています。新製品は、NFC Forum Type...
View ArticleClik here to view.
Iroko Pharmaceuticals发布在巴西商业化ZORVOLEX®的新战略协议
费城 (美国商业资讯) — Iroko Pharmaceuticals, LLC是一家致力于推动镇痛科学的全球性专科制药公司，该公司今天宣布，其附属公司Iroko Pharmaceuticals...
View ArticleClik here to view.
Theorem Clinical Research and Excel Life Sciences Form Strategic Relationship
KING OF PRUSSIA, Pa. Theorem Clinical Research and Excel Life Sciences (ELS) have formed a strategic relationship to bolster Theorem’s clinical development offerings in India, including local site...
View ArticleClik here to view.
ハーランとFluofarmaが戦略的提携契約を締結
スイス・イティンゲン （ビジネスワイヤ） — 受託研究サービス（CRS）事業を通じて一般的／専門的毒性検査サービスを提供する株式非公開企業のハーランラボラトリーズ・リミテッド（Harlan Laboratories, Ltd.）と、ハイコンテントアナリシスを専門とする医薬品開発業務受託機関のFluofarmaは、両社の創薬・橋渡し研究サービスを強化する戦略的提携を発表しました。...
View ArticleClik here to view.
Harlan与Fluofarma签署战略合作协议
瑞士伊廷根 (美国商业资讯) — Harlan Laboratories, Ltd.是一家私有的提供商，通过其合同研究服务(CRS)业务提供普通和专科毒理学服务，Fluofarma是一家专业从事高内涵分析的合同研究组织。两家公司宣布缔结战略伙伴关系，加强两家公司的药物发现和转化医学服务。 通过此联盟，Harlan...
View ArticleClik here to view.
Harlan and Fluofarma Sign Strategic Collaboration Agreement
ITINGEN, Switzerland Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS) business, and Fluofarma, a...
View ArticleClik here to view.
Investment Bridge Announces Investment Opinion: Bridge Report on ZEON...
TOKYO Investment Bridge, one of Japan’s leading independent IR services companies, has released a “Bridge Report” on ZEON CORPORATION (TOKYO:4205) reviewing its earnings results for full fiscal year...
View ArticleClik here to view.
Prefilled Syringes Market to Grow to 12.4 Billion Units by 2024, Predicts...
LONDON Roots Analysis has just released the 2nd edition of its publication “Prefilled Syringes Market, 2014-2024”, a comprehensive study on the product pipeline, technological progress, latest...
View Article